An increase in the expression of EZH2 is associated with increased proliferation, migration, and invasion of cancer cells in various types of cancer: hepatocellular carcinoma, ovarian carcinoma, gastric cancer, laryngeal squamous cell carcinoma, and prostate cancer (Figure 5). Here, EZH2 is linked to hepatocellular carcinoma.